Corcept Therapeutics
CORT
CORT
64 hedge funds and large institutions have $214M invested in Corcept Therapeutics in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% more call options, than puts
Call options by funds: $49K | Put options by funds: $38K
23% more funds holding
Funds holding: 52 → 64 (+12)
Holders
64
Holding in Top 10
2
Calls
$49K
Puts
$38K
Top Buyers
| 1 | +$5.2M | |
| 2 | +$4.18M | |
| 3 | +$1.56M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.26M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$1.09M |
Top Sellers
| 1 | -$2.05M | |
| 2 | -$179K | |
| 3 | -$113K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$79.7K |
| 5 |
SIM
Spark Investment Management
New York
|
-$76.8K |